A collection of medical studies shared online raised questions on Thursday over who knew what when, as the reports showed the CDC, since 2005, was aware of the anti-malaria drug’s efficacy against the Corona Virus, while researchers in China, Korea and France had been publishing the same since January.
Published in August, 2005, the CDC Special Pathogens Report confirms that at that time the Centers for Disease Control knew that Chloroquine can be used to treat the infection and spread of SARS coronavirus.
According to Chinese cell researchers Manli Wang, Ruiyuan Cao, Leike Zhang, Xinglou Yang, in January 2020, Chloroquine was recognized as a cheap and a safe drug that has been used for more than 70 years and, therefore, it is potentially clinically applicable against the 2019-nCoV strain.
In February, 2020, guidelines from South Korea and China report that hydroxychloroquine and chloroquine were effective antiviral therapeutic treatments for the virus.
In March, 2020, French scientists conducted an open-label non-randomized clinical trial by Didier Raoult M.D/Ph.D et al, completed just days ago. The Summary report finds that 100% of patients who received a combination of HCQ and Azithromycin tested negative and were virologically cured within six days of treatment.
Taken together, the reports beg the question of why did the CDC drag its feet about this old drug?
The two obvious answers are that Big Pharma, which bankrolls the CDC, as also described in the report, makes a lot more money from new antiviral patents than by having doctors prescribe a cheap generic. The second part, even more insidious, is that a pandemic with an easy cure isn’t much of a pandemic at all, so shrouding HDQ in uncertainty has prolonged the economic shutdown that has paralyzed the country, and pushed unemployment from 3% to 30%.
In 1983, Congress authorized the CDC to accept “external gifts” from industry and private parties, and in 1992 passed legislation for the creation of a nonprofit foundation to encourage relationships between industry and the agency. In fiscal year 2014, the CDC Foundation raised $52 million, $12 million of that from Big Pharma, according to a 2015 research report by the British Medical Journal.
Even though the CDC provides a disclaimer, “CDC, our planners, and our content experts wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products . . . CDC does not accept commercial support,” this does not prove to be the case.
On its website and in press releases and public pronouncements, the CDC recommends a person sick with the flu take an antiviral flu drug. It bases this recommendation on a study it claims is “independent, ” but the study cited was sponsored by Roche.
Roche manufactures the antiviral flu drug oseltamivir (known by the brand name Tamiflu). And the study’s four authors all had ties to Roche, Genentech or Gilead, which holds the patent on oseltamivir and has been profiting from these “outbreaks” for years.